We have more than 65 patent lawyers, technical specialists, and patent agents spanning our offices who have industry training and/or advanced degrees in life sciences and engineering, as well as experience as former patent office examiners well versed in the intricacies of the US Patent Office.
We work interactively with our clients to build and manage patent portfolios aligned with the client’s business goals, whether it be to develop a patent portfolio for a pre-clinical product of an early-stage company, a blockbuster biologic for a major pharmaceutical company, a medical device for a multinational corporation, or computer hardware for a consumer product company. We have extensive domestic and international patent prosecution experience and are successful at developing strategic plans for our clients. We draw on our experience in patent litigation, technology licensing and transfer, corporate financing, and business representation to assist our clients in shaping a patent portfolio that best serves their strategic business interests.
We work with clients’ patent committees, R&D and product development groups, research teams, engineers, and scientists to identify patentable subject matter and to devise patent prosecution strategies for maximizing global patent protection.
In addition to patent prosecution, we assist our clients with due diligence evaluations, patentability opinions, validity opinions, non-infringement opinions, and inventorship analyses and disputes. We partner with our clients to achieve their business objectives through acquisitions, joint ventures, collaborations, and public offerings.
McCarter’s life sciences intellectual property group has more than 25 PhD scientists with degrees in fields such as, molecular biology, cell biology, immunology, biochemistry, microbiology, virology, organic chemistry, and inorganic chemistry, and an MD. The group includes members with years of pharmaceutical industry experience, including both scientific and legal positions.
The scope and depth of our knowledge and training allows us to work as a team with our life sciences clients in all facets of intellectual property development, maintenance, and enforcement. We are experienced and innovative when it comes to the development and implementation of strategies for protecting our clients’ technologies.
Our firm clients include some of the biggest names in the biotechnology, pharmaceutical, university and life sciences fields for whom we are building and managing complex, patent portfolios protecting blockbuster biotech and small molecule drugs and developing global strategic plans.
Examples of areas in which members of the McCarter life sciences IP group have prosecuted patent applications include biomarkers, gene therapy, protein formulations, diagnostic assays, crystallography, RNA interference, biofuels, genetic engineering, small molecule pharmaceuticals, medical devices, polymer chemistry, formulations, and plant biotechnology. We also have extensive experience prosecuting antibody patents, including human antibodies, humanized antibodies, multispecific and/or multivalent antibodies, antibody production, and clinical uses of antibodies.
Our clients are discovering the latest technological advances that are changing the way we live, and McCarter’s patent team is active in all facets of these high tech sectors. Our technical knowledge spans the foundational engineering disciplines. We have more than 40 engineers providing the essential experience needed for effective and efficient IP prosecution and counseling services.
We regularly work with client patent committees, management, R&D and product development groups, laboratory teams, researchers, engineers, and scientists to determine appropriate patentable subject matter and to devise strategies for maximizing patent protection in the United States and internationally. In addition McCarter’s attorneys have comprehensive experience relating to freedom-to-operate studies, inventorship/ownership analyses and disputes, trade secrets issues, and proceedings before the Patent Trial and Appeal Board.
We have the legal and technical acumen to assist clients in numerous high-tech fields, such as biomedical technology, ceramics, drug delivery, nanotechnology, optoelectronics, optics, robotics, medical devices, telecommunications, advanced control systems, “green” technologies, biometrics, automotive technologies, software, distributed systems, networking, expert systems, microprocessor architectures, electronic circuitry, 3D display technologies, and a range of defense, aerospace, and energy technologies.
For the technology companies and research universities we represent, we have prosecuted patent applications in the areas of advanced control systems, telecommunications, color measurement, plasma physics devices, bio materials, bio fuel, fuel and solar cells, copper and fiber optic communication, medical devices and implants, surgical tools, laser devices, microprocessors, 3D visuals, nanotechnology-based products/systems, semiconductor, and computer hardware and software.